Home › Funds › PERCEPTIVE ADVISORS LLC › ADPT
PERCEPTIVE ADVISORS LLC position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
PERCEPTIVE ADVISORS LLC reported holding 1,217,325 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q2 2026 13F filing — a position valued at US$26.1M, representing 0.41% of its reported portfolio and ranking #50 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed ADPT holdings in 3 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's ADPT position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in ADPT in Q1 2025 at 930,972 shares (US$6.9M). The position peaked in Q2 2026 at 1,217,325 shares, worth US$26.1M. Across 3 filings, PERCEPTIVE ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,217,325 shares valued at US$26.1M — an increase of 1,064,825 shares quarter over quarter.. Notable position changes include a 698% increase in Q2 2026 (shares rose 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 930.97K | $6.92M | New |
| Q1 2026 | 152.50K | $2.12M | New |
| Q2 2026 | 1.22M | $26.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADPT and 13F data
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 52 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M sh · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M sh · $39.44M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M sh · $21.67M · Q2 2026
- Granite Investment Partners, LLC 757.22K sh · $16.24M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held ADPT?
PERCEPTIVE ADVISORS LLC has disclosed ADPT holdings in 3 of the last 6 reported quarters, going back to Q1 2025.
What is PERCEPTIVE ADVISORS LLC's current position in ADPT?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.22M shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $26.11M, representing 0.41% of its reported portfolio and ranking #50.
Has PERCEPTIVE ADVISORS LLC been buying or selling ADPT?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in ADPT. The position peaked in Q2 2026 at 1.22M shares.
Which other funds hold ADPT?
Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.